With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Single Cell RNA Sequencing of Pediatric High- and Low-Grade Gliomas||University of Colorado Denver / Adam Green, MD and Jean Mulcahy Levy, MD||Single-cell Pediatric Cancer Atlas Grant||2019||Colorado|
|Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells||The Johns Hopkins University School of Medicine / Satoshi Nakata, MD/PhD||Young Investigator Grants||2019||Maryland|
|Targeting Spinal Ependymoma and Other Gliomas Using Novel Genetically Defined Models||The Johns Hopkins University School of Medicine / Charles Eberhart, MD, PhD||Catalyst Grants||2019||Maryland|
|Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors||Children's Hospital of Philadelphia / Garrett Brodeur, MD||Reach Grants||2019||Pennsylvania|
|Targeting MYCN||Children's Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD||Crazy 8 Pilots||2019||Pennsylvania|
|Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome||Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD||Epidemiology Grants||2019||Pennsylvania|
|Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma||Children's Hospital of Philadelphia / Michael Chorny, PhD||Innovation Grants||2019||Pennsylvania|
|Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers||Children's Hospital of Philadelphia / Claudia Zapata, MD||Young Investigator Grants||2019||Pennsylvania|
|Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2019||Pennsylvania|
|Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Regina Myers, MD||Young Investigator Grants||2019||Pennsylvania|